
Development of Hemin-Activated Lipid Nanoparticles for Targeted Hemopexin Drug Delivery in Hemorrhagic Stroke
Intracerebral hemorrhage is bleeding directly into the brain, and pretty much no treatment exists: no drug therapies are approved, and only ~3% of patients qualify for surgery. Hemopexin can reduce brain damage by nearly 50%, but giving it too early can increase neuronal death by up to twelvefold. I developed nanoparticles designed to remain closed during that early window and release Hemopexin only when it is safe and effective to do so. The optimized formulation released nearly five times as much cargo in hemin-rich conditions while remaining stable under early-stroke conditions.
This independent project received Gold Grand Award – Minnesota’s highest science award, reserved for the top 5% of projects. It also received the 3M Young Inventor Recognition, including an invitation to present to scientists at 3M Global Headquarters, and the Dr. Victor Bedros Memorial Award for Excellence in Medical Sciences, which was awarded to three projects at the Twin Cities Regional Science Fair.
Watch the 2026 Minnesota State presentation ↗

